insurance no longer covering glp 1 Major changes are coming to GLP-1 drugs for weight loss. Here's how that could affect patients MCT2D | 2023 Updates to
Description
[DOI] [PubMed] [Google Scholar] 42.nalp A., nay B., Arhan E
138 To date, there are limited data on clinically significant metabolic enzyme- or transporter-mediated DDIs involving GLP-1 RAs and a dual GLP-1/GIP RA
doi: 10.1016/j.xcrm.2021.100387 [DOI] [PMC free article] [PubMed] [Google Scholar] 104
280 Importantly, the HELIOS-B trial included patients diagnosed at earlier stages of ATTR-CM with milder clinical manifestations, 264 reflecting a shift toward earlier intervention in ATTR-CM management
